Johnson & Johnson pauses COVID-19 vaccine trial as participant becomes ill
In this file photo taken on August 28, 2019 a sign on a building at the Johnson & Johnson campus shows their logo in Irvine, California. Johnson & Johnson said October 12, 2020, it had temporarily halted its Covid-19 vaccine trial because one of its participants had become sick.
AFP/Mark Ralston
Johnson & Johnson pauses COVID-19 vaccine trial as participant becomes ill
(Agence France-Presse) - October 13, 2020 - 10:20am

WASHINGTON, United States — Johnson & Johnson said Monday it had temporarily halted its COVID-19 vaccine trial because one of its participants had become sick.

"We have temporarily paused further dosing in all our COVID-19 vaccine candidate clinical trials, including the  Phase 3 ENSEMBLE trial, due to an unexplained illness in a study participant," the company said in a statement.

The pause means the online enrollment system has been closed for the 60,000-patient clinical trial while the independent patient safety committee is convened.

J&J said that serious adverse events (SAEs) are "an expected part of any clinical study, especially large studies." Company guidelines allowed them to pause a study to determine if the SAE was related to the drug in question and whether to resume study.

The J&J Phase 3 trial had started recruiting participants in late September, with a goal of enrolling up to 60,000 volunteers across more than 200 sites in the US and around the world.

The other countries where the trials were taking place are Argentina, Brazil, Chile, Colombia, Mexico, Peru and South Africa.

2019 N-COV COVID-19 VACCINE NOVEL CORONAVIRUS
Philstar
  • Latest
  • Trending
Latest
Are you sure you want to log out?
X
Login

Philstar.com is one of the most vibrant, opinionated, discerning communities of readers on cyberspace. With your meaningful insights, help shape the stories that can shape the country. Sign up now!

FORGOT PASSWORD?
SIGN IN
or sign in with